2026 Strategic Development of Public CDMO Services for Animal Cell-Based Vaccines and Production Support for Biotech Companies: Third-Round Recruitment of Beneficiaries
D-5Domestic pharmaceutical and biotech companies with technical capabilities but limited manufacturing infrastructure can receive support for process optimization and scale-up, cell bank production, preclinical or clinical trial sample production, and quality or stability testing. Production is supported indirectly through a public CDMO for animal cell-based vaccines.
- Ministry
- 산업통상부
- Implementing agency
- 동물세포실증지원센터
- Field
- Technology & R&D
- Eligible applicants
- Small and medium-sized enterprises
- Application period
- 2026-10-12 ~ 2026-10-30
- How to apply
- 이메일 접수 (minyoung@ipogiv.or.kr) ※ 신청서 제출 후 2일 이내에 접수 확인 메일이 도착하지 않을 경우, 이메일 또는 유선으로 접수 여부를 반드시 확인하시기 바랍니다.
- Contact
- 동물세포실증지원센터 기획관리실 054-842-6400, info@ipogiv.or.kr
Source: Bizinfo (bizinfo.go.kr) · updated 2026-10-25 · Name and summary translated from Korean; the official notice is in Korean.